Co-administration of cimetidine, nifedipine, oestrogen, or simvastatin with repaglinide, all CYP3A4 substrates, did not significantly alter the pharmacokinetic parameters of repaglinide.
La coadministración de cimetidina, nifedipina, estrógenos o simvastatina con repaglinida, todos los